XBIOTECH INC (XBIT)
CA98400H1029 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -24.56M | -32.90M | -17.41M | -11.22M | 668.63M | |||
| Depreciation Amortization | 1.74M | 2.61M | 2.65M | 2.24M | 2.36M | |||
| Income Taxes - Deferred | -59.00K | 0.00 | 530.00K | -90.00K | N/A | |||
| Change In Working Capital | 2.78M | 7.60M | 77.04M | -66.48M | 57.83M | |||
| Taxes Paid | N/A | N/A | 0.00 | 54.09M | N/A | |||
| Other non cash items | 1.37M | 7.86M | 6.64M | 10.40M | -747.09M | |||
| OPERATING CASH FLOW | -18.73M | -14.82M | 69.45M | -65.15M | -18.27M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -362.00K | -590.00K | -3.53M | -3.73M | -200.00K | |||
| Other Investing Activity | 61.86M | -63.31M | 0.00 | 0.00 | 675.00M | |||
| INVESTING CASH FLOW | 61.50M | -63.89M | -3.53M | -3.73M | 674.80M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | -9.00K | 0.00 | 8.00M | -409.72M | 41.79M | |||
| Dividend Paid | N/A | 0.00 | -75.00M | N/A | N/A | |||
| Other Financing Activity | N/A | N/A | 0.00 | 0.00 | 300.00K | |||
| FINANCING CASH FLOW | -9.00K | 0.00 | -67.01M | -409.72M | 42.10M | |||
| Exchange Rate Effect | -46.00K | -960.00K | 710.00K | 1.37M | 150.00K | |||
| CHANGE IN CASH | 42.72M | -79.67M | -380.00K | -477.23M | 698.78M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -18.73M | -14.82M | 69.45M | -65.15M | -18.27M | |||
| Capital Expenditure | -362.00K | -590.00K | -3.53M | -3.73M | -200.00K | |||
| FREE CASH FLOW | -19.09M | -15.41M | 65.92M | -68.88M | -18.47M | |||
All data in USD